ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 98 filers reported holding ADMA BIOLOGICS INC in Q4 2020. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $36,000 | -42.9% | 15,250 | -29.1% | 0.01% | -50.0% |
| Q2 2020 | $63,000 | +1.6% | 21,500 | 0.0% | 0.01% | -17.6% |
| Q1 2020 | $62,000 | -3.1% | 21,500 | +34.4% | 0.02% | +21.4% |
| Q4 2019 | $64,000 | -1.5% | 16,000 | +10.3% | 0.01% | -6.7% |
| Q3 2019 | $65,000 | +16.1% | 14,500 | 0.0% | 0.02% | +15.4% |
| Q2 2019 | $56,000 | +1.8% | 14,500 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $55,000 | – | 14,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 5,269,155 | $12,804,000 | 12.70% |
| Stonepine Capital Management, LLC | 5,000,000 | $12,150,000 | 5.46% |
| Altium Capital Management LP | 2,883,710 | $7,007,000 | 2.57% |
| AWM Investment Company, Inc. | 5,015,000 | $12,186,000 | 1.85% |
| Potomac Capital Management, Inc. | 482,000 | $1,171,000 | 1.34% |
| Perceptive Advisors | 10,933,387 | $26,568,000 | 0.77% |
| EAM Investors, LLC | 1,427,160 | $3,468,000 | 0.75% |
| Clearline Capital LP | 2,496,297 | $6,066,000 | 0.72% |
| EAM Global Investors LLC | 836,323 | $2,032,000 | 0.54% |
| BOOTHBAY FUND MANAGEMENT, LLC | 8,121,153 | $19,734,000 | 0.49% |